Xspray Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	153.75	208.24	166.3	120.17	271.88
Cash & Short-Term Investments	153.75	208.24	166.3	120.17	271.88
Cash Growth	-26.17%	25.21%	38.39%	-55.80%	-16.50%
Other Receivables	3.84	4.02	4.17	2.59	2.5
Receivables	3.84	4.02	4.17	2.59	2.5
Inventory	22.3	20.34	43.78	8.55	6.2
Prepaid Expenses	3.01	2.48	3.57	0.93	1.48
Other Current Assets	0	0	-	-0	-0
Total Current Assets	182.9	235.07	217.82	132.23	282.07
Property, Plant & Equipment	70.99	79.18	107.65	64.6	44.6
Long-Term Investments	0	0	0	0	0
Long-Term Deferred Charges	512.19	478.93	436.78	385.6	296.24
Other Long-Term Assets	3.27	3.17	3.02	3	-
Total Assets	769.35	796.34	765.26	585.43	622.9
Accounts Payable	3.32	17.08	12.47	14.79	16.87
Accrued Expenses	11.85	18.63	16.31	11.41	10.3
Short-Term Debt	-	96	-	-	-
Current Portion of Leases	5.36	5.11	4.86	1.57	2.05
Other Current Liabilities	1.13	9.31	6.26	1.09	0.75
Total Current Liabilities	21.66	146.14	39.9	28.85	29.97
Long-Term Debt	121.32	-	-	-	-
Long-Term Leases	21.72	27.11	31.95	0.56	1.19
Other Long-Term Liabilities	-	-0	-	-	-
Total Liabilities	164.7	173.25	71.85	29.41	31.15
Common Stock	41.74	37.14	31.25	22.68	20.68
Additional Paid-In Capital	1,574	1,425	1,216	907.42	813.48
Retained Earnings	-1,012	-840.25	-554.72	-374.08	-242.41
Comprehensive Income & Other	0.55	1	0.79	-	-
Shareholders' Equity	604.65	623.1	693.41	556.02	591.75
Total Liabilities & Equity	769.35	796.34	765.26	585.43	622.9
Total Debt	148.39	128.22	36.81	2.13	3.23
Net Cash (Debt)	5.35	80.02	129.5	118.04	268.65
Net Cash Growth	-93.31%	-38.21%	9.70%	-56.06%	-16.23%
Net Cash Per Share	0.14	2.41	4.87	5.60	13.96
Filing Date Shares Outstanding	41.74	37.14	31.25	22.68	20.68
Total Common Shares Outstanding	41.74	37.14	31.25	22.68	20.68
Working Capital	161.23	88.93	177.91	103.38	252.1
Book Value Per Share	14.49	16.78	22.19	24.52	28.61
Tangible Book Value	604.65	623.1	693.41	556.02	591.75
Tangible Book Value Per Share	14.49	16.78	22.19	24.52	28.61
Machinery	-	51.5	52.12	49.82	46.96
Construction In Progress	-	41.39	59.37	46.57	20.04

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.